devinitorg/iati-policy-markers huggingface dataset:
Medicines Patent Pool Foundation III The aim of the Foundation is to remove market entry barriers for generic ARVs through "pro-public health" voluntary licenses, in as many countries as possible, and to facilitate the development of FDCs and paediatric formulations.
Autotest, libre d'accéder à la connaissance de son Statut VIH Increasing access to self-testing for HIV (HIVST) among target populations, promote linkage to prevention, care and treatment, thereby reducing the number of HIV infections, HIV related deaths, and disability adjusted life years.
Preventing patent barriers This project aims to prevent the creation of patent-based market entry barriers, or, where such barriers already exist, remove them, for medicines for HIV, TB and hepatitis C, as well as other HIV co-infections agreed to by UNITAID approved and under development)
Access to Treatment for People Living with HIV in Middle Income Countries The project aims to use TRIPS flexibilities to remove barriers to generic competition for 2nd and 3rd line ARVs. This will result in lower prices in four intervention countries (Argentina, Brazil, Thailand, Ukraine) and expand the overall market for newer ARVs. In addition, the proponents will work toward reform of intellectual property (IP) laws or regulations in order to facilitate continued/future use of such flexibilities
Multi-Drug Resistant (MDR)-TB Scale-up and Acceleration of Access Project The aim of this joint Project (otherwise known as the MDR-TB Scale-up Initiative) is to scale-up access to quality assured anti-TB drugs to treat MDR-TB patients in eligible countries and positively impact the dynamics of the MDR-TB drug market
WHO TB Enabler The goal of the WHO TB Enabler grant is to enable and accelerate adoption and uptake of new TB diagnostics, drugs and new regimens in high burden countries. The project will do this by enabling a policy environment that facilitates and accelerates access to innovations within integrated TB management in countries.
Ensuring access to the HCV treatment revolution for HCV/HIV co-infected patients in low and middle income countries The 3-year project plans to shape sustainable markets to ensure those living with HIV-HCV in low- and middle-income countries have rapid access to products for HCV, taking advantage of changes to the HCV landscape, including entry of directly-acting antivirals (DAAs) that are administered orally
Malaria Vaccine Implementation Programme (MVIP) Phase 2 Malaria Vaccine Implementation Programme (MVIP) Phase 2
Operational Studies to Validate and Accelerate Uptake of Point-of-Care CD4 Counters The projectc aims to support the introduction of a novel point-of-care CD4 diagnostic to the market in sub-Saharan Africa, Latin America, and South-east Asia at affordable prices.  This will be done through clinical validation of the Daktari CD4 system; enhancing manufacturing capacity development; and conducting operational studies for regulatory approval. (The product is a battery-powered, point-of-care CD4 testing system, which will provide a CD4 cell count result in less than 12 minutes from a finger stick of blood)
Unitaid support to WHO prequalification of medicines and in vitro diagnostics, and to the WHO collaborative procedure for registration Unitaid support to WHO prequalification of medicines and in vitro diagnostics, and to the WHO collaborative procedure for registration
WHO HTM Enabler Grant This enabling project aims to ensure that outputs from UNITAID’s investments in the areas of HIV and hepatitis C virus (HCV) are translated into public health policy and ultimately have global impact.
RTS,S/AS01 Pilot Implementation Programme This project aims to operationalize the WHO recommendation for pilot implementation of the new malaria vaccine, RTS,S/AS01, and the evaluation of feasibility, impact, and safety of the vaccine when used in a routine immunization programme. The overall goal of the Malaria Vaccine Implementation Programme is to achieve a WHO policy recommendation on the use of the RTS,S/AS01 malaria vaccine in young children in sub-Saharan Africa.
Accelerating Measurable Progress and Leveraging Investments for PPH impact Accelerating Measurable Progress and Leveraging Investments for PPH Impact
THRIVE (Transforming Advanced HIV Disease CaRe in LMICs through ComprehensiVe and Equitable Access) THRIVE (Transforming Advanced HIV Disease CaRe in LMICs through ComprehensiVe and Equitable Access)
Paediatric HIV/AIDS Treatment Project The goal of the Project is to maintain on-going access to paediatric ARVs, diagnostic bundles and related components. The project is also increasing the sustainability of the paediatric marketplace through the use of supplier selection techniques that increase the number of quality assured paediatric products and reduce their prices. The project is also working to identify long-term funding sources for paediatric ARVs and related commodities and support countries in securing these funds
Broad One Health Endectocide-based Malaria Intervention in Africa (BOHEMIA) This project focuses on product development for new vector control tools. It will develop strategies to reduce malaria transmission based on ivermectin mass drug administration (MDA) as the first-in-class endectocide to be evaluated for this indication and will work on dissemination and stakeholder engagement activities to create country demand for this vector control tool. In addition, the project will contribute to the evidence base for endectocides as a complement to existing vector control strategies to inform WHO policy.
ADVANCING SPATIAL REPELLENTS FOR VECTOR-BORNE DISEASE CONTROL The University of Notre Dame’s project–Advancing Spatial Repellents for Vector-borne Disease Control–will evaluate slow-release spatial repellents that can be easily deployed in houses and temporary shelters. The repellants are delivered via small, clear plastic sheets hung in strategic spots.
Research to expand access to Heat-Stable Carbetocin for the treatment of Postpartum Haemorrhage Research to expand access to Heat-Stable Carbetocin for the treatment of Postpartum Haermorrhage
A randomised trial to compare dolutegravir + pharmaco-enhanced darunavir versus recommended standard of care antiretroviral regimens in patients with HIV infection who have failed recommended first-line therapy The project goal is to contribute to scale-up of improved second-line ARV treatment.
Medicines Patent Pool Foundation II The aim of the Foundation is to remove market entry barriers for generic ARVs through "pro-public health" voluntary licenses, in as many countries as possible, and to facilitate the development of FDCs and paediatric formulations.
WHO HEALTH EMERGENCIES PROGRAM (WHE- 1) WHE Oxygen Technical Assistance & Acute Biomedical Needs Procurement Project
Accelerating Patient Access to Optimal Antiretrovials The Goal of this project is to contribute to the scale-up of Optimal ARVs at the global level.
Achieving Catalytic Expansion of SMC Services in the Sahel to Save Lives The project aims to expand seasonal malaria chemoprevention (SMC) in 7 countries (Burkina Faso, Chad, Guinea, Mali, Niger, Nigeria, The Gambia), in order to accelerate impact and build markets for SMC products
Supply Side grant The overarching goal of the MMV Supply Grant is to increase access to malaria chemoprevention and severe malaria commodities. The outcome of the project is to improve increased availability and supply of quality assured malaria chemoprevention and severe malaria products.
Malaria market intelligence to evaluate global investments and define sustainable strategic options that ensure access to high quality commodities Market intelligence for malaria products
Scaling up access to contemporary diagnostics for tuberculosis (GeneXpert) with a focus on HIV-associated TB, drug-resistant TB and early TB case detection The TBXpert Project will scale up TB diagnostic testing using state-of-the-art Xpert MTB/RIF, providing approximately 1.4 million Xpert MTB/RIF test cartridges and over 200 GeneXpert instruments for the rapid detection of TB and rifampicin resistance in 21 recipient countries. To ensure country absorptive capacity and effective use of the technology, the TBXpert project links a broad network of partners and existing initiatives for TB laboratory strengthening to expand access to vulnerable populations in the public and private sector
Enabling access to a robust and well-tolerated new-generation first-line antiretroviral treatment in low-income countries he NAMSAL trial, which is sponsored and co-funded by the French National Agency of Research on AIDS & Hepatitis (ANRS) and would be implemented by the Institut Bouisson Bertrand (IBB) and the Institut de Recherche pour le Développement (IRD), aims to generate robust evidence on the clinical and economic benefits of a dolutegravir (DTG)-based regimen in an African setting, representative of real-world conditions within resources-constrained settings. The study protocol has been reviewed and approved by the appropriate authorities. UNITAID is requested to co-fund this trial by supporting the purchase of the study drugs for the duration of the 48-week trial, and after completion of the trial for a duration of up to three years for post-trial access if the new regimen is not yet accessible by then to the study participants via the National Program.
Rapid, comprehensive targeted gene sequencing solution for drug-resistant TB diagnosis in LMICs The project aims to facilitate a transformation of the diagnosis and treatment of DR-TB by accelerating the introduction and global adoption of commercial targeted sequencing for affordable, scalable and rapid DST with near-real time networked interpretation and global reporting
Preparedness for the Rollout of Effective HIV Prevention among Key Affected Populations in Brazil, Peru and Mexico The main goal of the project is to contribute to the reduction in HIV incidence among MSM and TGW in Brazil, Mexico and Peru through the inclusion of PrEP as a component of comprehensive HIV prevention provided by public services.
(PQ Dx II) WHO Prequalification of Medicines and Diagnostics: Increased access to appropriate, quality-assured diagnostics, medical devices and medicines for the prevention, initiation and treatment of HIV/AIDS, TB and Malaria The project aims to increase the number of quality assured tools to diagnose and monitor treatment for HIV/AIDS and malaria. The project also provides support to strengthen regulatory capacity and post marketing surveillance of diagnostic tests in five pilot countries.
TOWARDS ELIMINATION OF CONGENITAL TRANSMISSION OF CHAGAS DISEASE IN LATIN
AMERICA (CUIDA CHAGAS) To  complement to the Fiotec/Fiocruz led Consortium for the project "Towards Elimination of Congenital Transmission of Chagas Disease in Latin America (CUIDA Chagas) and falls under the Area for Intervention (AfI) Towards the elimination of congenital infection in Chagas disease through better tools for diagnosis and treatment.
Accelerating tools to drive tuberculosis detection (DriveDx4TB) Accelerating tools to drive tuberculosis detection (DriveDx4TB)
TB SPEED: Strengthening paediatric TB services for enhanced early detection The goal is to contribute to the reduction in childhood mortality from tuberculosis by delivering an available, feasible, cost-effective, and decentralized childhood tuberculosis diagnostic approach to enhance case-finding and access to treatment.
Unitaid Explore To accelerate the development, regulatory approval and commercialisation of an innovative taste-masked paediatric fixed-dose combination of artesunate/amodiaquine for the treatment of paediatric malaria based on the Recipient’s MicroCoat technology for use in low-resource settings
Access to COVID-19 Tools Accelerator (“ACT-A”) Fund the MPP’s work within the Access to COVID-19 Tools Accelerator (“ACT-A”) during 2022.
Adherence Support Coalition to End TB (ASCENT) The project will increase access to more cost-effective, fit-for-purpose and comprehensive digital adherence technologies (DATs) in low and middle-income countries (LMICs).
UNICEF, WHO: UNITAID support to Liberia & Burundi for supply of ACTs for 2007 This project intends to support the delivery of ACT treatments for malaria for Burundi and Liberia on an exceptional, emergency basis to prevent stock outs of these medicines during the malaria season in these countries. UNITAID resources will be used to finance the purchase of ACT treatments only
Affordable Medicines Facility - Malaria (AMFm) The AMFm objective is to significantly reduce the price for ACT treatments paid by end-users through a subsidy mechanism to the private sector. This is essential to increase access to effective malaria treatment and to delay the development of resistance to artemisinin. AMFm is currently implemented through nine programs in eight countries: Cambodia, Ghana, Kenya, Madagascar, Niger, Nigeria, Tanzania and Uganda
Vayu Explore Late Stage Development and Regulatory Approval of the Vayu bCPAP and Low-Flow Blender Circuit Devices
Catalyse uptake of Under-utilised Tools & Treatment Simplification for HEP C (CUTTS HepC) Catalyse uptake of Under-utilised Tools & Treatment Simplification for HEP C (CUTTS HepC)
Accelerating access and integration of innovative point of care (POC) HIV technologies in national diagnostics programs Phase 2b To accelerate access to innovative point of care diagnostics, jointly implemented by Clinton Health Access Initiative (CHAI) and United Nations Children’s Fund (UNICEF), in 7 high burden countries
Research to expand access to Heat-Stable Carbetocin for the treatment of Postpartum Haemorrhage Research to expand access to Heat-Stable Carbetocin for the treatment of Postpartum Haemorrhage
Transforming IPT for Optimal Pregnancy (TIPTOP) The project will create a pathway based on local evidence and buy-in to sustain and scale up an innovative, community-based approach to expand coverage of intermittent preventive treatment in pregnancy (IPTp) for pregnant women, in four project countries and eventually across sub-Saharan Africa (SSA).
Malaria Prevention-Long Lasting Insecticide Treated Nets (LLINs) LLINs delivered to country, either held in port awaiting release or awaiting distribution as of 28 August 2009 (from 1st interim report of UNICEF to UNITAID, 31 August 2009)
UNICEF: PMTCT Expansion (PMTCT II) Expansion of PMTCT 1 to 9 additional countries (mid-2009-mid-2011). Central African Republic, China, Haiti, Lesotho, Myanmar, Nigeria, Swaziland, Uganda, Zimbabwe
Implementation of CD4 and VL testing in decentralized resource-limited settings MSF engages in operational research on introduction of PoC and adapted laboratory-based monitoring to understand how, where and when PoC fits in the mix of laboratory services available in the health services. Eleven different MSF-supported HIV/AIDS programs in the seven project countries engage in complementary work to compare different strategies and identify the most feasible and affordable options for optimal deployment and use of diagnostic tests in given types of resource-constrained settings
Cost containment, price reductions and increased access to first-line anti-TB drugs The project provides first line TB medicines through transitional grants to minimize the risk of stock outs and therefore drug resistance among patients in countries that will face a gap in drug supply between the end of a GDF grant and the start of a planned future source of funding for first line anti-TB medicines
Améliorer l'Identification des Détresses Respiratoires chez l'Enfant The grant aims to increase effective referrals from primary health care to district hospitals, in the West-African context, where appropriate care should be available to improve child survival. This will be achieved by increasing access and use of pulse oximeters at the primary health care level.. The AIRE project will conduct an operational research focused on creating a proof of concept for the use of pulse oximeters in primary health facilities)
Accelerating demand for HIVST among young people in Western and Southern Africa This grant will create demand for HIVST and PrEP among young people (15-24) in South Africa and Côte d'Ivoire by developping 3 TV Shuga series. It uses a 360 approach consisting of an array of tools (graphic novels, peer guides, radio programmes, social media) to reach the highest number of at risk youth possible.
TRANSFORM -Tranexamic acid access for all mothers with bleeding after childbirth TRANSFORM -Tranexamic acid accessforall mothers with bleeding after childbirth
Expanding the use of TRIPS flexibilities to promote affordable access to medicines To provide government policymakers and CSOs in LMIC with, a service on how to use TRIPS flexibilities, training, global fora on TRIPS flexibility and educational visits, research and publication and guides.
Innovate, Involve, Inspire: Preventing Hepatitis C through Community-led Harm Reduction (HEPC III) Innovate, Involve, Inspire: Preventing Hepatitis C Through Community-Led Harm Reduction (HEPC III)
Additional Support to the Coordinated Procurement Planning (CPP) Initiative The project aims to establish a common framework for understanding stock out risks, improving funding coordination and procurement and supply management of medicines for HIV/AIDS, TB and malaria. The financial contribution of UNITAID is to develop a publically accessible database and web-platform to improve information sharing between the CPP Members and to be more effective in preventing stock outs. Six countries are included in the initial phase of the project: Angola, Burkina Faso, Cameroon, Central African Republic, Mali, and Mozambique
Expand TB - MDR TB Diagnostics, Expanding and accelerating access to diagnostics for patients at risk of multi-drug resistant tuberculosis The project accelerates access to MDR TB diagnosis by introducing new and rapid technologies and laboratory service together with the necessary know-how for technology transfer. The intention is to identify an estimated 115,000 MDR TB patients in 27 countries to enable appropriate treatment of these patients
ACT Scale up initiative The ACT Scale-up project was initiated to provide 47,016,160 high quality ACT treatments to seven countries. The project covers 11 programs chosen because of their participation in the GFATM round grants
Catalyzing Paediatric TB Innovations The main expected impact (Goal) of this project is to reduce morbidity and mortality associated with pediatric TB.
WHO HEALTH EMERGENCIES PROGRAM (WHE- 2) WHE Oxygen Technical Assistance & Acute Biomedical Needs Procurement Project
Expand New Drugs for TB (endTB) EndTB aims to radically change the MDR-TB (multidrug resistant tuberculosis) market by accelerating uptake of the newly released MDRTB drugs (bedaquiline and delamanid) in 16 countries. The intervention will have long-term market effects that will consolidate the market for MDR-TB drugs, expanding access to new, effective, and user-friendly  treatment regimens for patients with MDR-TB
Integrating PrEP into Comprehensive Services for Adolescent Girls and Young Women The objectives of this grant are to increase accessibility of PrEP for eligible adolescent population in the project implementation areas; demonstrate effective delivery models and appropriate use of PrEP amongst adolescents; generate and disseminate evidence on the use of PrEP in adolescence.
Support to Round 6 of the Global Fund to fight AIDS, TB and Malaria This project aims to scale up access to treatment and to improve affordability of medicines for AIDS, MDR-TB and malaria through Global Fund grants in Round 6, Phase 1 for 42 grants in 37 countries
Accelerating access to Innovative POC HIV diagnostics The project intends to prepare the market for accelerated scale-up of POC HIV Dx: CD4, VL and EID by working with 7 high-volume early adopter countries to prepare for rapid scale-up of POC Dx, while helping new suppliers through the regulatory and policy approval processes
Uptake of a Novel, Disposable CD4 Point-of-Care CD4 Test in Developing Countries The overall goal of this project is the uptake of the Zyomyx CD4 test in 12 low and middle income countries. The Grantee shall seek to achieve successful field evaluations of the test, together with regulatory approvals, the scale up of manufacturing capacity and distribution of the test, in accordance with the commercialization and access
Open polyvalent platforms for sustainable and quality access to Viral Load in resource limited settings The Project improves access to viral load testing (VLT) and early infant diagnosis (EID) for adults and children living with HIV through the introduction of innovative Open Polyvalent Platforms (OPPs). During Phase I of the Project, the lead project implementer, France Expertise International (FEI), will work with other partners to develop a full Business Plan for scaled-up commercialization of VLT/OPP, prepare a proposal for the second phase of the Project, develop a procurement strategy and plan for the 4 project target countries  and commence deployment on OPPs in these countries
Creating a Private Sector Market for Quality Assured RDTs in Malaria-Endemic Countries PSI and the collaborating implementers, Malaria Consortium (MC), FIND, and WHO/Global Malaria Programme (GMP), will stimulate the creation of a private sector market for malaria RDTs.  The partnership will operate in five target countries  where the UNITAID-supported AMFm has been implemented.  The project is designed as a  catalytic market intervention to develop methods and to learn and to disseminate experience and project lessons learned to accelerate the introduction and scale up of malaria RDTs in the private sector
UNICEF: Acceleration of Prevention of Mother-to-Child Transmission (PMTCT) and Scale up of Linkages to Paediatric HIV Care and Treatment for 2007-2009
Enabling Access – Medical Innovations For All IP-TRIPS Enabling Access – Medical Innovations For All
Start taking actionfor TB diagnosis (START 4 All) Start taking actionfor TB diagnosis (START 4 All)
E-market place for the procurement of public health commodities To generate savings and increase access to health products and related commodities by facilitating healthy markets to better utilize resources in the fight against the three diseases (AIDS, tuberculosis, malaria)
Market Intervention to accelerate uptake of new vector control tools The project aims to increase use of third generation IRS (3GIRS) products in Insecticide Resistance Management Programmes
Tools for Integrated Management of Childhood Illness The grant aims to improve the detection of severe disease in children under five, including newborns, by equipping primary health care workers with pulse oximeters and decision support tools to enhance their ability to diagnose severe disease. Also, it will accelerate the development and market entry of non-invasive devices that augment the features of standard pulse oximeters with one or more additional vital sign measurements.
IMproved Access to AHD Care and Treatment 4HIV - IMPAACT4HIV IMproved Access to AHD Care and Treatment 4HIV / IMPAACT4HIV
Unitaid Explore The  purpose  of  the  Project  is  to  accelerate  the  development,  regulatory  approval  and 
UnitaidExplore – Funding Agreement (DelSi Tech)2commercialisation of   a long-acting injectable paediatric formulation based on the Recipient’s Silica Matrix technology  for  use  in  low-resource  settings  (the  “Health  Product”).
mRNA Project Norway to fund the MPP’s implementation of the South African mRNA Technology Transfer Hub Project, (“the mRNA Project”)
UNICEF: PMTCT Nutrition Nutritional care linked to PMTCT in 4 of the PMTCT 1 countries (mid-2009-mid-2011). Malawi, Rwanda, Tanzania, Zambia.
Catalytic Long Lasting Insecticidal Nets (LLIN) initiative Continued reduction in malaria incidence, morbidity and mortality by the establishment of a sustainable market for a broader set of LLIN tools, which perform in areas of pyrethroid resistance, and have the potential to support insecticide-resistance management.
Long-acting injectable formulation of ivermectin as a new vector control tool to reduce malaria transmission (IMPACT) ​The IMPACT project will develop long-acting injectable ivermectin to fight malaria transmission